Head-To-Head Contrast: CONMED Corporation (CNMD) vs. Its Competitors

CONMED Corporation (NASDAQ: CNMD) is one of 84 public companies in the “Medical Equipment, Supplies & Distribution” industry, but how does it contrast to its rivals? We will compare CONMED Corporation to similar companies based on the strength of its analyst recommendations, valuation, institutional ownership, profitability, earnings, risk and dividends.

Valuation and Earnings

This table compares CONMED Corporation and its rivals gross revenue, earnings per share (EPS) and valuation.

Gross Revenue EBITDA Price/Earnings Ratio
CONMED Corporation $772.61 million $123.91 million 92.02
CONMED Corporation Competitors $827.05 million $159.46 million 34.85

CONMED Corporation’s rivals have higher revenue and earnings than CONMED Corporation. CONMED Corporation is trading at a higher price-to-earnings ratio than its rivals, indicating that it is currently more expensive than other companies in its industry.


This table compares CONMED Corporation and its rivals’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
CONMED Corporation 2.02% 8.38% 3.66%
CONMED Corporation Competitors -128.72% -37.35% -10.53%

Institutional & Insider Ownership

98.3% of CONMED Corporation shares are owned by institutional investors. Comparatively, 63.2% of shares of all “Medical Equipment, Supplies & Distribution” companies are owned by institutional investors. 2.6% of CONMED Corporation shares are owned by company insiders. Comparatively, 12.9% of shares of all “Medical Equipment, Supplies & Distribution” companies are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.


CONMED Corporation pays an annual dividend of $0.80 per share and has a dividend yield of 1.6%. CONMED Corporation pays out 142.9% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. As a group, “Medical Equipment, Supplies & Distribution” companies pay a dividend yield of 0.8% and pay out 37.3% of their earnings in the form of a dividend.

Analyst Recommendations

This is a summary of current ratings and target prices for CONMED Corporation and its rivals, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
CONMED Corporation 0 3 1 0 2.25
CONMED Corporation Competitors 322 1480 2596 105 2.55

CONMED Corporation presently has a consensus target price of $49.33, indicating a potential downside of 4.26%. As a group, “Medical Equipment, Supplies & Distribution” companies have a potential upside of 6.56%. Given CONMED Corporation’s rivals stronger consensus rating and higher possible upside, analysts clearly believe CONMED Corporation has less favorable growth aspects than its rivals.

Risk & Volatility

CONMED Corporation has a beta of 0.68, meaning that its stock price is 32% less volatile than the S&P 500. Comparatively, CONMED Corporation’s rivals have a beta of 1.08, meaning that their average stock price is 8% more volatile than the S&P 500.


CONMED Corporation rivals beat CONMED Corporation on 10 of the 15 factors compared.

CONMED Corporation Company Profile

CONMED Corporation is a medical technology company. The Company is engaged in the development, manufacturing and sale on a global basis of surgical devices and related equipment. The Company provides surgical devices and equipment for minimally invasive procedures. The Company’s products are used by surgeons and physicians in a range of specialties, including orthopedics, general surgery, gynecology, neurosurgery and gastroenterology. The Company’s product lines consist of orthopedic surgery, general surgery and surgical visualization. As of December 31, 2016, the Company’s products are distributed domestically directly to over 6,000 hospitals, surgery centers and other healthcare institutions, as well as through medical specialty distributors. The Company’s orthopedic surgery product lines include sports medicine, powered surgical instruments, and sports biologics and tissue. These products are marketed under a range of brands, including Hall, CONMED Linvatec, Concept and Shutt.

Receive News & Ratings for CONMED Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CONMED Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply